<?xml version="1.0" encoding="UTF-8"?>
<p>Undoubtedly, standardization of NGS-based methods, including data processing, will lay a foundation for their widespread integration into clinical routine. Existing algorithms for analyzing sequence output, given user-friendly graphical interfaces, should become easy to handle even without expert knowledge of Linux commands. Another important step is the creation of reliable, comprehensive drug-resistance databases that will enable detection of clinically significant strains required for the special treatment. Such databases are already available for HIV [
 <xref rid="B217-viruses-12-00211" ref-type="bibr">217</xref>], HBV [
 <xref rid="B218-viruses-12-00211" ref-type="bibr">218</xref>,
 <xref rid="B219-viruses-12-00211" ref-type="bibr">219</xref>] and HCV [
 <xref rid="B220-viruses-12-00211" ref-type="bibr">220</xref>].
</p>
